BCL2 Binding Component 3 (BBC3) (N-Term) Peptide
-
- Target See all PUMA (BBC3) products
- PUMA (BBC3) (BCL2 Binding Component 3 (BBC3))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- TTWVPCQICG PRERHGPRTP GGQLPGARRG PGPRRPAPLP ARPPGALGSV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BBC3 Antibody(ARP58945_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PUMA (BBC3) (BCL2 Binding Component 3 (BBC3))
- Synonyms
- BBC3 Peptide, Puma Peptide, JFY-1 Peptide, JFY1 Peptide, PUMA Peptide, PUMA/JFY1 Peptide, BCL2 binding component 3 Peptide, Bcl-2 binding component 3 Peptide, BBC3 Peptide, Bbc3 Peptide, bbc3 Peptide
- Background
-
BBC3 is an essential mediator of p53-dependent and p53-independent apoptosis.
Alias Symbols: FLJ42994, JFY1, PUMA, JFY-1
Protein Interaction Partner: BCL2,BAX,BCL2,BCL2,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L1,BCL2L2,BNC1,MCL1,BAX,BCL2,BCL2A1,BCL2L1,BCL2L2,MCL1,BCL2,BCL2L1,MCL1
Protein Size: 261 - Molecular Weight
- 26 kDa
- Gene ID
- 27113
- NCBI Accession
- NM_001127240, NP_001120712
- UniProt
- Q96PG8
-